Skip to main content
. 2012 Apr 9;109(17):6668–6673. doi: 10.1073/pnas.1203756109

Table 1.

Association of rs62527607[GT] genotype and BAALC expression in the test set and validation set and in the two sets combined

Test set
Validation set
Combined sets
BAALC expression Low, n = 134 (%) High, n = 119 (%) *P value Low, n = 53 (%) High, n = 52 (%) *P value Low, n = 187 (%) High, n = 171 (%) **P value
Genotype counts GG 108 (81) 70 (59) 43 (81) 36 (69) 151 (81) 106 (62)
GT 20 (15) 46 (39) 8 (15) 16 (31) 28 (15) 62 (36)
TT 6 (5) 3 (3) 2 (4) 0 (0) 8 (4) 3 (2)
GT + TT 26 (19) 49 (41) 2.01 × 10−4 10 (19) 16 (31) 0.16 36 (19) 65 (38) 9.30 × 10−5
OR (95% CI) 2.91 (1.67, 5.16) 1.91 (0.78, 4.86) 2.59 (1.62, 4.22)
Allele count G 236 (88) 186 (78) 94 (89) 88 (85) 330 (88) 274 (74)
T 32 (12) 52 (22) 3.16 × 10−3 12 (11) 16 (15) 0.39 44 (12) 68 (18) 2.83 × 10−3
OR (95% CI) 2.06 (1.28, 3.06) 1.42 (0.64, 3.24) 1.87 (1.25, 2.85)

Test set, Cancer and Leukemia Group B; validation set, German-Austrian AML Study Group. All P values for genotypes compare GG with GT+TT and are obtained from *univariable or **multivariable logistic regression analyses. CI, confidence interval; OR, odds ratio.